Overview - BSC News highlights five new BNB Chain tokens for potential investors [1] - The analysis encourages further research and reminds readers that it is not financial advice [1] Token Performance - EGLL (EGL1): Community/$USD1 sector, market cap of $1021 million, launched in Q2 2025 [1] - LIBERTY: Community/$USD1 sector, market cap of $104 million, launched in Q2 2025 [1] - SIREN: AI/Community sector, market cap of $473 million, launched in Q1 2025 [1] - TAG: AI sector, market cap of $751 million, launched in Q4 2024 [1] - TUT: Education/Community sector, market cap of $673 million, launched in Q1 2025 [1] Listing Platforms - Binance Alpha lists EGL1, SIREN, and TAG [1] - Bitget lists EGL1, SIREN, TAG, and TUT [1] - MEXC lists EGL1, LIBERTY, SIREN, TAG, and TUT [1] - Kucoin lists SIREN and TUT [1]

Overview of Emerging BNB Chain Tokens - BSC News highlights five new BNB Chain tokens for potential investors [1] Token Sector and Market Cap - Community/$USD1 sector includes EGLL (EGL1) with a market cap of $1021 million and Liberty (LIBERTY) with a market cap of $104 million [1] - AI sector is represented by Siren (SIREN) with a market cap of $473 million and TaggerAI (TAG) with a market cap of $751 million [1] - Education/Community sector includes Tutorialtoken (TUT) with a market cap of $673 million [1] Token Launch Dates - Siren (SIREN) and Tutorialtoken (TUT) launched in Q1 2025 [1] - EGLL (EGL1) and Liberty (LIBERTY) launched in Q2 2025 [1] - TaggerAI (TAG) launched in Q4 2024 [1] Token Listings - Binance Alpha lists EGLL (EGL1), Siren (SIREN), and TaggerAI (TAG) [1] - Bitget lists EGLL (EGL1), Siren (SIREN), TaggerAI (TAG), and Tutorialtoken (TUT) [1] - MEXC lists EGLL (EGL1), Liberty (LIBERTY), Siren (SIREN), TaggerAI (TAG), and Tutorialtoken (TUT) [1] - Kucoin lists Siren (SIREN) and Tutorialtoken (TUT) [1]

Cryptocurrency Market - BNB Chain 上 2025 年值得关注的 5 大代币包括：$EGL1、$TUT、$SIREN、$TAG 和 Torch of $Liberty [1]

BNB Chain Tokens - 2025 年值得关注的 BNB Chain 上 Top 5 代币包括：$EGL1, $TUT, $SIREN, $TAG & Torch of $Liberty [1]

Market Overview - BSC News highlights five new BNB Chain tokens for potential investors [1] - The tokens span across sectors like Community, AI, and Education [1] Token Performance - EGLL_american (EGL1) has a market cap of $102.1 million [1] - liberty_bsc (LIBERTY) has a market cap of $104 million [1] - genius_sirenBSC (SIREN) has a market cap of $47.3 million [1] - TaggerAI (TAG) has a market cap of $75.1 million [1] - tutorialtoken (TUT) has a market cap of $67.3 million [1] Launch and Listing - EGL1 and LIBERTY launched in Q2 2025 [1] - SIREN and TUT launched in Q1 2025 [1] - TAG launched in Q4 2024 [1] - Binance Alpha, Bitget, MEXC, and Kucoin are common listing platforms [1]

Overview - BSC News highlights five new BNB Chain tokens for potential investors [1] - The analysis encourages further research and reminds readers that it is not financial advice [1] Token Performance - EGLL (EGL1): Community/$USD1 sector, market cap of $1021 million, launched in Q2 2025 [1] - LIBERTY: Community/$USD1 sector, market cap of $104 million, launched in Q2 2025 [1] - SIREN: AI/Community sector, market cap of $473 million, launched in Q1 2025 [1] - TAG: AI sector, market cap of $751 million, launched in Q4 2024 [1] - TUT: Education/Community sector, market cap of $673 million, launched in Q1 2025 [1] Listing Platforms - Binance Alpha lists EGL1, SIREN, and TAG [1] - Bitget lists EGL1, SIREN, TAG, and TUT [1] - MEXC lists EGL1, LIBERTY, SIREN, TAG, and TUT [1] - Kucoin lists SIREN and TUT [1]

Overview of New BNB Chain Tokens - BSC News highlights five new BNB Chain tokens for potential investors [1] Token Sectors - Two tokens focus on the Community/$USD1 sector: EGLL_american ($EGL1) and liberty_bsc ($LIBERTY) [1] - Two tokens are in the AI sector: genius_sirenBSC ($SIREN) and TaggerAI ($TAG) [1] - One token focuses on the Education/Community sector: tutorialtoken ($TUT) [1] Market Capitalization (MC) - liberty_bsc ($LIBERTY) has the highest MC at $104 million [1] - EGLL_american ($EGL1) has an MC of $1021 million [1] - TaggerAI ($TAG) has an MC of $751 million [1] - tutorialtoken ($TUT) has an MC of $673 million [1] - genius_sirenBSC ($SIREN) has the lowest MC at $473 million [1] Launch Dates - TaggerAI ($TAG) launched in Q4 2024 [1] - genius_sirenBSC ($SIREN) and tutorialtoken ($TUT) launched in Q1 2025 [1] - EGLL_american ($EGL1) and liberty_bsc ($LIBERTY) launched in Q2 2025 [1] Exchange Listings - Binance Alpha, Bitget, and MEXC list multiple tokens [1] - Kucoin lists genius_sirenBSC ($SIREN) and tutorialtoken ($TUT) [1]

$100M Incentive Program: Purchase AnnouncementThe BNB Chain Foundation wallet has made new asset purchases. Here are the details:✅ Swapped USDT 25k to TAG (@TaggerAI) 40,421,479.45 @ 0.0006184830526https://t.co/BTxMXqPngC🔍 BNB Chain Foundation Wallet address:https://t.co/aI2L3HaAoaBNB Chain (@BNBCHAIN):BNB Chain’s $100M Incentive Program Gets an Upgrade! ⬆️After a 3-week pilot, feedback showed the current program wasn’t effective.Now, BNB Chain is testing a new direct token acquisition method to improve the ...

Trump's World Liberty(@worldlibertyfi) spent 200K $USD1 to buy 78,922 $B($40K), 409,387 $Liberty($40K), 396,371 $EGL1($40K), 72,917,613 $TAG($40K) and 636,683 $BANK($40K) an hour ago.https://t.co/SUBbhLzUyZ https://t.co/XgUh9Hg8fI ...

Financial Data and Key Metrics Changes - The company reported total revenue of $1.4 billion, reflecting a 4% growth on a reported basis and 1% organic growth. Excluding $148 million from CSL and the whole blood divestiture, organic growth was 8% [9][10] - Adjusted gross margin for the fourth quarter was 60.2%, an increase of 620 basis points compared to the prior year, driven by volume growth and improved product mix [27][29] - Adjusted net income for fiscal year 2025 was $231.5 million, up $28 million or 14%, with adjusted earnings per diluted share at $4.57, up 15% compared to the prior year [32] Business Line Data and Key Metrics Changes - Hospital revenue grew 12% in the quarter and 24% in fiscal year 2025 on a reported basis, with organic growth of 9% respectively [12] - Blood Management Technologies revenue grew 6% in the quarter and 10% in fiscal year 2025, driven by strong utilization and share gains [12][13] - The Interventional Technologies franchise delivered 21% reported growth in the quarter and 46% in fiscal year 2025, with 16% organic growth respectively [14] Market Data and Key Metrics Changes - Plasma revenue declined 9% in the quarter and 6% in fiscal year 2025 due to the planned CSL transition, but excluding CSL, plasma revenue grew 11% in the fourth quarter and 5% for fiscal year 2025 [20][22] - Blood center revenue declined 22% in the quarter and 8% in fiscal year 2025 on a reported basis due to the whole blood divestiture [23] - The company anticipates plasma revenue to decline 7% to 10% on a reported basis in fiscal year 2026, with organic growth expected to be 11% to 14% excluding CSL [22][25] Company Strategy and Development Direction - The company is focused on advancing its innovation agenda and sharpening its focus on high-growth opportunities following the divestiture of the whole blood business [31] - The leadership team has been strengthened with new appointments to support scalable long-term growth, particularly in hospital businesses [11] - The company expects to achieve adjusted operating margin improvement to 26% to 27% in fiscal year 2026, supported by continued gains in adjusted gross margin [36] Management's Comments on Operating Environment and Future Outlook - Management remains confident in the strong growth trajectory of the hospital business, projecting reported and organic revenue growth of 8% to 11% in fiscal year 2026 [17] - The company anticipates challenges in the first half of fiscal year 2026 but expects a rebound in collections in the second half [98] - Management highlighted the importance of cash flow generation and expects free cash flow in fiscal year 2026 to be in the range of $160 million to $200 million [38] Other Important Information - The company executed a $150 million share buyback, repurchasing approximately 2.4 million shares, reflecting its commitment to value creation [11] - The adjusted income tax rate was 22% for the fourth quarter and 23% for fiscal year 2025, compared to 21% to 23% for the respective periods of the prior year [31] Q&A Session Summary Question: Insights on plasma collections and guidance - Management remains bullish on plasma, indicating that the 11% to 14% growth guidance is primarily driven by share gains and technology adoption, with modest growth expected in the first half of fiscal year 2026 [46][48] Question: EPS guidance and drivers - The operating margin guidance of 26% to 27% is supported by continued improvement in gross margin and operational efficiencies, with a $0.20 impact from tariffs factored into the guidance [50][53] Question: Vascular closure portfolio performance - Management noted strong growth from newer products like MVP and XL, with efforts focused on improving performance in the legacy PCI side of the business [59][61] Question: Revenue and EPS progression throughout the year - Management indicated that revenue and margin expansion will progress over the course of the year, with a second half load expected due to ongoing growth initiatives [94][97] Question: Update on VIVUSURE Medical acquisition - The company maintains a long-term appetite for acquisitions, with a focus on integrating recent acquisitions before pursuing new opportunities [78][80]